Restricted accessResearch articleFirst published online 2014-09
Presence of qnr,aac(6′)-Ib,qep A,oqx AB,and Mutations in Gyrase and Topoisomerase in Nalidixic Acid–Resistant Salmonella Isolates Recovered from Retail Chicken Carcasses
Four hundred sixty-two nalidixic acid– and/or ciprofloxacin-resistant Salmonella isolates were examined for presence of quinolone-resistance mechanisms. A total of 339 amino acid substitutions were identified in GyrA (204) and ParC (135). Ser83Phe/Asp87Gly (29.4%) were most commonly detected in GyrA in 136 isolates, and to a lesser extent of Asp87Asn (22.8%), Asp87Gly (19.1%), Ser83Phe/Asp87Asn (19.1%), and Ser83Tyr (5.1%). Ser80Arg (97.0%) was detected in ParC in 132 isolates. Simultaneous mutations in GyrA and ParC (n=109) were commonly detected to be Ser83Phe/Asp87Gly(GyrA)-Ser80Arg(ParC) (35.8%), Asp87Asn(GyrA)-Ser80Arg(ParC) (22.9%), and Ser83Phe/Asp87Asn(GyrA)-Ser80Arg(ParC) (21.1%). qnrA, qnrB, qnrS, aac(6′)-Ib, qepA, and oqxAB were detected in 52 (11.3%), 64 (13.9%), 11(2.4%), 107 (23.2%), 6 (1.3%), and 194 (42.0%) of 462 isolates, respectively. Isolates carried more qnr, aac(6′)-Ib, qepA, and oqxAB genes, and amino acid substitution in GyrA and ParC was more resistant to nalidixic acid and fluoroquinolones.
Get full access to this article
View all access options for this article.
References
1.
BlazquezJ. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis, 2003; 37:1201–1209.
2.
CattoirV, PoirelL, RotimiV, et al.Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother, 2007; 60:394–397.
3.
ChenS, ZhaoS, WhiteDG, et al.Characterization of multiple-antimicrobial-resistant Salmonella serovars isolated from retail meats. Appl Environ Microbiol, 2004; 70:1–7.
4.
ChenX, ZhangWQ, PanWJ, et al.Prevalence of qnr, aac(6′)-Ib-cr, qepA, and oqxAB in Escherichia coli isolates from humans, animals, and the environment. Antimicrob Agents Chemother, 2012; 56:3423–3427.
5.
[CLSI] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing 2010, 20th International ed. CLSI Document M100-S20. Wayne, PA: CLSI, 2010.
DeekshitVK, KumarBK, RaiP, et al.Detection of class 1 integrons in Salmonella Weltevreden and silent antibiotic resistance genes in some seafood-associated nontyphoidal isolates of Salmonella in south-west coast of India. J Appl Microbiol, 2012; 112:1113–1122.
8.
DimitrovT, UdoEE, AlbaksamiO, et al.Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin. J Med Microbiol, 2007; 56:277–279.
9.
EavesDJ, LiebanaE, WoodwardMJ, et al.Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. J Clin Microbiol, 2002; 40:4121–4125.
10.
EavesDJ, RandallL, GrayDT, et al.Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother, 2004; 48:4012–4015.
11.
GiraudE, BrisaboisA, MartelJL, et al.Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother, 1999; 43:2131–2137.
12.
HiroseK, HashimotoA, TamuraK, et al.DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob Agents Chemother, 2002; 46:3249–3252.
LeClercJE, LiB, PayneWL, et al.High mutation frequencies among Escherichia coli and Salmonella pathogens. Science, 1996; 274:1208–1211.
15.
LeeHY, SuLH, TsaiMH, et al.High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob Agents Chemother, 2009; 53:2696–2699.
16.
LiXZ. Quinolone resistance in bacteria, emphasis on plasmid-mediated mechanisms. Int J Antimicrob Agents, 2005; 25:453–463.
17.
LingJM, ChanEW, LamAW, et al.Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother, 2003; 47:3567–3573.
18.
MeadPS, SlutskerL, DietzV, et al.Food-related illness and death in the United States. Emerg Infect Dis, 1999; 5:607.
19.
NordmannP, PoirelL. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother, 2005; 56:463–469.
20.
ParkCH, RobicsekA, JacobyGA, et al.Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother, 2006; 50:3953–3955.
21.
PiddockLJV. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol Rev, 2002; 26:3–16.
22.
RobicsekA, JacobyGA, HooperDC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis, 2006a;6:629–640.
23.
RobicsekA, StrahilevitzJ, SahmDF, et al.Qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother, 2006b;50:2872–2874.
24.
RibotEM, FairMA, GautomR, et al.Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis, 2006; 3:59–67.
25.
Sjölund-KarlssonM, FolsterJP, PecicG, et al.Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States. Antimicrob Agents Chemother, 2009; 53:2142–2144.
26.
VeldmanK, CavacoLM, MeviusD, et al.International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries. J Antimicrob Chemother, 2011; 66:1278–1286.
27.
WangMG, TraJH, JacobyGA, et al.Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother, 2003; 47:2242–2248.
28.
World Health Organization. Overcoming Antimicrobial Resistance, A Message from the Director-General, World Health Organization. 2000. Available at: http//www.who.int/infectious-disease-report/2000/other_versions/index-rpt2000_text.html, accessed May23, 2013.
29.
WuWY, WangH, LuJ, et al.Genetic diversity of Salmonella enterica serovar Typhi and Paratyphi in Shenzhen, China from 2002 through 2007. BMC Microbiol, 2010; 10:32.
30.
YangB, ZhengJ, BrownEW, et al.Characterization of antimicrobial resistance-associated integrons and mismatch repair gene mutations in Salmonella serotypes. Int J Antimicrob Agents, 2009; 33:120–124.
31.
YangB, XiM, WangX, et al.Prevalence of Salmonella on raw poultry at retail markets in China. J Food Prot, 2011; 74:1724–1728.
